Press Releases
MOBILion Systems Launches MOBIE: The First SLIM-Based HRIM Product to Accelerate Biotherapeutic Drug Development and Multiomic Biomarker Discovery
MOBILion Systems Inc. has announced the launch of its first commercial High-Resolution Ion Mobility (HRIM) product, MOBIE, which addresses characterization challenges faced during biopharmaceutical drug development and quality monitoring. MOBIE provides fast, efficient separations with superior resolution and reproducibility,...
Press Releases
Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Tabuk Pharmaceutical Manufacturing Company, a leading Saudi pharmaceuticals company, announced an agreement to commercialize the Moderna COVID-19 Vaccine and future variant-specific booster candidates in Saudi Arabia.
Under...
Packaging & Labelling
FedEx Extends Support, Donates Third Dedicated Charter Flight Carrying Critical COVID-19 Aid to India
In continued effort to support India and combat the second wave of COVID-19, FedEx Express, a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, announced the arrival of a third dedicated charter flight carrying...
Packaging & Labelling
Emirates SkyCargo expands pharma cool chain infrastructure in Dubai, enhancing vaccine transport capabilities
Emirates SkyCargo is further strengthening its temperature sensitive pharma and vaccine handling capabilities in Dubai with the extension of its fully automated cool room with 94 airline pallet positions at its EU GDP certified dedicated pharma facility at Dubai...
Press Releases
Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, announced a new agreement to commercialize the Moderna COVID-19 Vaccine across Central Eastern...
Clinical Trials
INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced an expansion of its previously announced partnership with Advaccine Biopharmaceuticals Suzhou Co., Ltd....
Drug Research
Biogen and Eisai launch multiple initiatives to help patients with Alzheimer’s disease access ADUHELM
Following today’s U.S. FDA accelerated approval of ADUHELMTM as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease by reducing amyloid beta plaques in the brain, Biogen and Eisai Inc., U.S. subsidiary of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















